Citadel Advisors - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAD3. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$12,225,021
-61.5%
11,901,000
-57.3%
0.00%
-57.1%
Q1 2023$31,737,623
-57.4%
27,901,000
-63.2%
0.01%
-58.8%
Q4 2022$74,474,061
-16.4%
75,901,000
-0.8%
0.02%
-15.0%
Q3 2022$89,082,000
-2.0%
76,490,000
-11.6%
0.02%
-13.0%
Q2 2022$90,901,00086,490,0000.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 25,000,000$26,265,0002.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 32,000,000$33,439,0000.69%
AQR Arbitrage LLC 28,460,000$29,840,0000.67%
WOLVERINE ASSET MANAGEMENT LLC 23,359,000$24,559,0000.25%
FRANKLIN RESOURCES INC 63,000,000$66,056,0000.03%
Citadel Advisors 86,490,000$90,901,0000.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 600,000$626,0000.01%
LINDEN ADVISORS LP 500,000$522,0000.01%
BlackRock Inc. 2,925,000$3,052,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PTC THERAPEUTICS INC shareholders